← Open Payments lookup

SAMUEL REALISTA: Open Payments

NPI 1194052811 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,676 in 17 payments from 11 companies in 2025. Trend: 2023 $207 · 2024 $729 · 2025 $1,676

Food & beverage: $1,676
CompanyPaymentsAmount
Gilead Sciences, Inc.2$259
ABIOMED2$229
Novo Nordisk Inc2$228
GENZYME CORPORATION2$152
Medtronic, Inc.1$146
AstraZeneca Pharmaceuticals LP1$132
Neurocrine BioSciences, Inc.1$125
Amgen Inc.1$117
Axsome Therapeutics, Inc.1$117
Teva Pharmaceuticals USA, Inc.1$100

Products named: SYMPLICITY G3, BREZTRI, Livdelzi, Epclusa, INGREZZA, Wegovy, REPATHA, Auvelity.

Industry payments across FL — which companies pay providers there.